Investigation Report on China's Metoprolol Market, 2018-2022

Publisher Name :
Date: 14-Nov-2018
No. of pages: 30

Description

Estimated according to the population size and structure, there are about 330 million hypertensive patients in China, which means that one in every three adults suffers from hypertension. Chinese hypertensive patients in China account for about one-third of the global total. The incidence of hypertension in China rose from 5.1% in 1959 to 37.2% in 2017 by 32.1%. With so many hypertensive patients, China's antihypertensive drug market is growing steadily.

There are various antihypertensive drugs in China, which leads to fierce competition. As first-line antihypertensive drugs in China, ?-blockers represented by Metoprolol, Bisoprolol, Perindopril and benazepril have a stable market share. Metoprolol is a selective ?1 receptor blocker that treats cardiovascular diseases, especially hypertension, angina and tachycardia. The Metoprolol Tartrate preparations approved to be marketed in China include tablets, capsules, sustained-release tablets, controlled-release tablets and injections. AstraZeneca's proprietary drug is sold in the trade name of Betaloc. In addition, generic Metoprolol produced by over 10 manufacturers are also sold in China. According to CRI's market research, the market size of Metoprolol in China was about CNY 492 million in 2017, of which AstraZeneca accounted for more than 90%. The top Chinese companies included Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Shanghai Sine Promod Pharmaceutical Co., Ltd. and Zhuhai Tongyuan Pharmaceutical Co., Ltd.

As the number of hypertensive patients is growing with the rapidly aging population, and generic ?-blockers are popularized, it is expected that Metoprolol will still have some growth potential in China.

Topics Covered:


  • Situation of hypertension in China

  • Sales of Metoprolol in China

  • Major Metoprolol manufacturers in China

  • Competition on China's Metoprolol market

  • Driving forces and opportunities for China's Metoprolol market

  • Forecasts on China's Metoprolol market from 2018 to 2022

Investigation Report on China's Metoprolol Market, 2018-2022

Table of Contents

1 Relevant Concepts of Metoprolol
1.1 Indications for Metoprolol
1.2 Development of Metoprolol in China
1.3 Patents and Government Approval on Metoprolol in China

2 Sales of Metoprolol in China, 2013-2017
2.1 Sales Value of Metoprolol
2.2 Sales Volume of Metoprolol
2.3 Sales of Metoprolol by Dosage Form in China, 2013-2017

3 Analysis on Major Metoprolol Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Metoprolol Manufacturers
3.2 AstraZeneca
3.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
3.4 Shanghai Sine Promod Pharmaceutical Co., Ltd.
3.5 Zhuhai Tongyuan Pharmaceutical Co., Ltd.
3.6 Changzhou Siyao Pharmaceuticals Co., Ltd.

4 Prices of Metoprolol in China, 2017-2018
4.1 AstraZeneca (Betaloc)
4.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (Lijunning)
4.3 Shanghai Sine Promod Pharmaceutical Co., Ltd.
4.4 Zhuhai Tongyuan Pharmaceutical Co., Ltd.
4.5 Changzhou Siyao Pharmaceuticals Co., Ltd.

5 Prospect of China's Metoprolol Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

List of Charts

Chart Sales of Metoprolol in China, 2013-2017
Chart Sales Value of Metoprolol in Parts of China, 2013-2017
Chart Sales Volume of Metoprolol in China, 2013-2017
Chart Sales Volume of Metoprolol in Parts of China, 2013-2017
Chart Sales Value of Metoprolol Injections in China, 2013-2017
Chart Sales Volume of Metoprolol Injections in China, 2013-2017
Chart Sales Value of Metoprolol Tablets in China, 2013-2017
Chart Sales Volume of Metoprolol Tablets in China, 2013-2017
Chart Market Share of Top 5 Metoprolol Manufacturers by Sales Value, 2013-2017
Chart Market Share of Top 5 Metoprolol Manufacturers by Sales Volume, 2013-2017
Chart Sales Value of AstraZeneca's Metoprolol, 2013-2017
Chart Sales Volume of AstraZeneca's Metoprolol, 2013-2017
Chart Sales Value of Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.'s Metoprolol, 2013-2017
Chart Sales Volume of Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.'s Metoprolol, 2013-2017
Chart Sales Value of Shanghai Sine Promod Pharmaceutical Co., Ltd.'s Metoprolol, 2013-2017
Chart Sales Volume of Shanghai Sine Promod Pharmaceutical Co., Ltd.'s Metoprolol, 2013-2017
Chart Sales Value of Zhuhai Tongyuan Pharmaceutical Co., Ltd.'s Metoprolol, 2013-2017
Chart Sales Volume of Zhuhai Tongyuan Pharmaceutical Co., Ltd.'s Metoprolol, 2013-2017
Chart Sales Value of Changzhou Siyao Pharmaceuticals Co., Ltd.'s Metoprolol, 2013-2017
Chart Prices of AstraZeneca's Metoprolol in Parts of China, 2017-2018
Chart Prices of Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.'s Metoprolol in Parts of China, 2017-2018
Chart Prices of Shanghai Sine Promod Pharmaceutical Co., Ltd.'s Metoprolol in Parts of China, 2017-2018
Chart Prices of Zhuhai Tongyuan Pharmaceutical Co., Ltd.'s Metoprolol in Parts of China, 2017-2018
Chart Prices of Changzhou Siyao Pharmaceuticals Co., Ltd.'s Metoprolol in Parts of China, 2017-2018
Chart Forecast on Sales Value of Metoprolol in China, 2018-2022

  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs